The Asian Hospital and Medical Center, established on 15 March 2000 is the first private tertiary hospital built in the southern part of Metro Manila, with Jorge Garcia, MD, an alumnus of the Faculty of Medicine & Surgery of the University of Santo Tomas, as its founding chairman.

There are 312 beds in Asian Hospital and Medical Center.

During the past decade, Asian Hospital and Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asian Hospital and Medical Center" #1 sponsor was "Société des Produits Nestlé (SPN)" with 3 trials, followed by "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asian Hospital and Medical Center" #1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator, "International Vaccine Institute" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Asian Hospital and Medical Center" are "COVID-19" (2 trials), "Infant Term Birth" (2 trials), "Arthritis" (1 trials), "Feeding Disorder" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Asian Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Asian Hospital and Medical Center" are "Biological" (4 trials), "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Experimental Infant Formula" (2 trials), "Paclitaxel" (2 trials), "Standard Infant Formula" (2 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asian Hospital and Medical Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Asian Hospital and Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asian Hospital and Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asian Hospital and Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".